The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in older individuals worldwide. The disease is characterized by abnormal extracellular deposits, known as drusen, that accumulate along the basal surface of the retinal pigmented epithelium. Although drusen deposition is common in older individuals, large numbers of drusen and/or extensive areas of confluent drusen represent a significant risk factor for AMD. Widespread drusen deposition is associated with retinal pigmented epithelial cell dysfunction and degeneration of the photoreceptor cells of the neural retina. Recent studies have shown that drusen contain a variety of immunomodulatory molecules, suggesting that the process of drusen formation involves local inflammatory events, including activation of the complement cascade. Similar observations in Alzheimer's disease (AD) have lead to the hypothesis that chronic localized inflammation is an important element of AD pathogenesis, with significant neurodegenerative consequences. Accordingly, the amyloid beta (Aβ) peptide, a major constituent of neuritic plaques in AD, has been implicated as a primary activator of complement in AD. Here we show that Aβ is associated with a substructural vesicular component within drusen. Aβ colocalizes with activated complement components in these “amyloid vesicles,” thereby identifying them as potential primary sites of complement activation. Thus, Aβ deposition could be an important component of the local inflammatory events that contribute to atrophy of the retinal pigmented epithelium, drusen biogenesis, and the pathogenesis of AMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Complement components, other inflammatory molecules, lipids, lipoproteins B and E, and glycoproteins are common constituents of ocular drusen (Johnson et al., 2002).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Johnson et al., 2002
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Bustin, S. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250169 · Cited by 3,872
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Self-citationA role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Self-citationMullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
Self-citationNormal and Abnormal Biology of the beta-Amyloid Precursor Protein
Selkoe, D. J. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.002421 · Cited by 818
Complement activation by beta-amyloid in Alzheimer disease.
Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817
Johnson, L. V., Leitner, W. P., Staples, M. K., & Anderson, D. H. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1094 · Cited by 621
Self-citationAccumulation of cholesterol with age in human Bruch's membrane.
Curcio, C. A., Millican, C. L., Bailey, T. A., & Kruth, H. S. (2001) · PubMed · Cited by 508
Immune System Response in Alzheimer's Disease
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029863 · Cited by 459
Research works printed but not linked: 9
- G S Hageman, P J Luthert, N H V Chong, L V Johnson, D H Anderson, R F Mullins Progr. Ret. Eye Res., eds N N Osborne, G J Chader (Elsevier Science, London) 20, 705–732 (2001).
- H Lin, D O Clegg Invest Ophthalmol Visual Sci 39, 1703–1712 (1998).
- K S Kim, D L Miller, V J Sapienza, C M J Chen, C Bai, I Grundke-Iqbal, J R Currie, H M Wisniewski Neurosci Res Comm 2, 121–130 (1988).
- K S Kim, G Y Wen, C Bancher, C M J Chen, V J Sapienza, H Hong, H M Wisniewski Neurosci Res Commun 7, 113–122 (1990).
- D A Simpson, S Feeney, C Boyle, A W Stitt Mol Vis 6, 178–183 (2000).
- C A Curcio, C L Millican, T Bailey, H S Kruth Invest Ophthalmol Visual Sci 42, 265–274 (2001).
- K Loeffler, D Edward, M Tso Invest Ophthalmol Visual Sci 36, 24–31 (1995).
- R P Burns, L Feeney-Burns Trans Am Ophthalmol Soc 78, 206–225 (1980).
- R J Ulshafer, C B Allen, B Nicolaissen, M L Rubin Invest Ophthalmol Visual Sci 28, 683–689 (1987).
Cited by
Items 101–200 of 495
Danis, R. P., Lavine, J. A., & Domalpally, A. (2015) · Clinical ophthalmology · doi:10.2147/opth.s92359 · Cited by 106
NLRP3 Inflammasome and Pathobiology in AMD
Celkova, L., Doyle, S., & Campbell, M. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4010172 · Cited by 104
Association of Drusen Deposition with Choroidal Intercapillary Pillars in the Aging Human Eye
Lengyel, I., Tufail, A., Hosaini, H. A., Luthert, P., Bird, A. C., & Jeffery, G. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-1083 · Cited by 103
NLRP3 Inflammasome: Activation and Regulation in Age‐Related Macular Degeneration
Gao, J., Liu, R. T., Cao, S., Cui, J. Z., Wang, A., To, E., & Matsubara, J. A. (2015) · Mediators of Inflammation · doi:10.1155/2015/690243 · Cited by 101
Crabb, J. W. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017194 · Cited by 100
Immunotherapy for Alzheimer's disease
Wisniewski, T., & Goñi, F. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.020 · Cited by 100
Pasricha, M. V., Sleiman, K., Tai, V., Chiu, S. J., Winter, K. P., Stinnett, S. S., Hwang, T. S., Hubbard, G. B., Michelson, M., Gunther, R., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.08.047 · Cited by 100
Muszyński, P., Groblewska, M., Kulczyńska-Przybik, A., Kułakowska, A., & Mroczko, B. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170208124324 · Cited by 99
Chiu, K., Chan, T.-F., Wu, A., Leung, I. Y.-P., So, K.-F., & Chang, R. C.-C. (2012) · AGE · doi:10.1007/s11357-011-9260-2 · Cited by 99
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Mroczko, B., Groblewska, M., Litman-Zawadzka, A., Kornhuber, J., & Lewczuk, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071884 · Cited by 97
“It appears that insoluble Aβ deposits are recognized as foreign material and trigger activation of inflammatory response cascade [55,56].”
BackgroundKalariya, N. M., Ramana, K. V., Sk, S., & van Kuijk, F. J. G. M. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.09.010 · Cited by 97
Dasari, B., Prasanthi, J. R. P., Marwarha, G., Singh, B. B., & Ghribi, O. (2010) · BMC Ophthalmology · doi:10.1186/1471-2415-10-22 · Cited by 97
Wang, L., & Mao, X. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052360 · Cited by 97
Liu, R. T., Wang, A., To, E. C., Gao, J., Cao, S., Cui, J. Z., & Matsubara, J. A. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.07.003 · Cited by 95
Retinal and Cerebral Microvascular Signs and Diabetes
Qiu, C., Cotch, M. F., Sigurdsson, S., Garcia, M., Klein, R., Jonasson, F., Klein, B. E. K., Eiriksdottir, G., Harris, T. B., van Buchem, M. A., et al. (2008) · Diabetes · doi:10.2337/db07-1455 · Cited by 94
Klingeborn, M., Dismuke, W. M., Skiba, N. P., Kelly, U., Stamer, W. D., & Bowes Rickman, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-05102-9 · Cited by 94
Parry, D. A., Toomes, C., Bida, L., Danciger, M., Towns, K. V., McKibbin, M., Jacobson, S. G., Logan, C. V., Ali, M., Bond, J., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.04.005 · Cited by 94
Apolipoprotein Localization in Isolated Drusen and Retinal Apolipoprotein Gene Expression
Li, C.-M., Clark, M. E., Chimento, M. F., & Curcio, C. A. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1446 · Cited by 93
Colligris, P., de Lara, M. J. P., Colligris, B., & Pintor, J. J. (2018) · Journal of Ophthalmology · doi:10.1155/2018/8538573 · Cited by 93
The Role of Complement Factor H in Age-related Macular Degeneration: A Review
Donoso, L. A., Vrabec, T. R., & Kuivaniemi, H. (2010) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2009.11.001 · Cited by 92
Amyloid-β Immunotherapy for Alzheimers Disease
Fu, H. J., Liu, B., Frost, J. L., & Lemere, C. A. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791012017 · Cited by 91
Interplay between aging and other factors of the pathogenesis of age-related macular degeneration
Błasiak, J., Sobczuk, P., Pawłowska, E., & Kaarniranta, K. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101735 · Cited by 90
Pead, E., Megaw, R. D., Cameron, J. R., Fleming, A., Dhillon, B., Trucco, E., & MacGillivray, T. (2019) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2019.02.003 · Cited by 91
Bonnel, S., Mohand-Said, S., & Sahel, J.-A. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00093-7 · Cited by 89
Hakobyan, S., Harris, C. L., Tortajada, A., Goicochea de Jorge, E., Garci´a-Layana, A., Ferna´ndez-Robredo, P., Rodri´guez de Co´rdoba, S., & Morgan, B. P. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1523 · Cited by 89
Association of complement factor H Y402H gene polymorphism with Alzheimer's disease
Zetterberg, M., Landgren, S., Andersson, M. E., Palmér, M. S., Gustafson, D. R., Skoog, I., Minthon, L., Thelle, D. S., Wallin, A., Bogdanovic, N., et al. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30668 · Cited by 88
Kurji, K. H., Cui, J. Z., Lin, T., Harriman, D., Prasad, S. S., Kojic, L., & Matsubara, J. A. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-3622 · Cited by 87
McLaughlin, T., Medina, A., Perkins, J., Yera, M., Wang, J. J., & Zhang, S. X. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00528-w · Cited by 85
Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina
Dasari, B., Prasanthi, J. R. P., Marwarha, G., Singh, B. B., & Ghribi, O. (2011) · BMC Ophthalmology · doi:10.1186/1471-2415-11-22 · Cited by 82
Intracellular amyloid beta alters the tight junction of retinal pigment epithelium in 5XFAD mice
Park, S. W., Kim, J. H., Mook‐Jung, I., Kim, K.-W., Park, W. J., Park, K. H., & Kim, J. H. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.008 · Cited by 81
Wang, J., Ohno-Matsui, K., Yoshida, T., Kojima, A., Shimada, N., Nakahama, K.-I., Safranova, O., Iwata, N., Saido, T. C., Mochizuki, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.712 · Cited by 80
Picard, E., Houssier, M., Bujold, K., Sapieha, P., Lubell, W., Dorfman, A., Racine, J., Hardy, P., Febbraio, M., Lachapelle, P., et al. (2010) · Aging · doi:10.18632/aging.100218 · Cited by 80
Interconnection Between Brain and Retinal Neurodegenerations
Jindal, V. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8733-6 · Cited by 82
Prematurely senescent ARPE-19 cells display features of age-related macular degeneration
Glotin, A., Debacq‐Chainiaux, F., Brossas, J., Faussat, A., Tréton, J., Zubielewicz, A., Toussaint, O., & Mascarelli, F. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.12.023 · Cited by 78
Age-Related Macular Degeneration and Risk of Degenerative Dementia among the Elderly in Taiwan
Tsai, D., Chen, S., Huang, C., Yuan, M.-K., & Leu, H. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.07.033 · Cited by 77
Role of the choroid in age-related macular degeneration: A current review
Ebrahimi, K., & Farazdaghi, M. (2019) · Journal of Ophthalmic and Vision Research · doi:10.4103/jovr.jovr_125_18 · Cited by 76
Choi, S., Jahng, W. J., Park, S. M., & Jee, D. (2020) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2019.11.001 · Cited by 75
Assessment of neuroprotection in the retina with DARC
Guo, L., & Cordeiro, M. F. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)01130-8 · Cited by 74
Inflammation in Dry Age-Related Macular Degeneration
Rodrigues, E. B. (2007) · Ophthalmologica · doi:10.1159/000099293 · Cited by 73
REFRACTILE DRUSEN: Clinical Imaging and Candidate Histology
Suzuki, M., Curcio, C. A., Mullins, R. F., & Spaide, R. F. (2015) · Retina · doi:10.1097/iae.0000000000000503 · Cited by 73
Criscuolo, C., Fabiani, C., Bonadonna, C., Origlia, N., & Domenici, L. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.11.016 · Cited by 73
Antibody therapies and their challenges in the treatment of age-related macular degeneration
Volz, C., & Pauly, D. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.020 · Cited by 73
Kawa, M. P., Machalińska, A., Rogińska, D., & Machaliński, B. (2014) · Journal of Immunology Research · doi:10.1155/2014/483960 · Cited by 73
Lin, T. R., Walker, G., Kurji, K. H., Fang, E., Law, G., Prasad, S. S., Kojic, L., Cao, S., White, V. A., Cui, J. Z., et al. (2013) · Cytokine · doi:10.1016/j.cyto.2013.03.027 · Cited by 72
Shah, T. M., Gupta, S. M., Chatterjee, P., Campbell, M., & Martins, R. N. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.251 · Cited by 73
Epigenetics, microbiota, and intraocular inflammation: New paradigms of immune regulation in the eye
Wen, X., Hu, X., Li, M., Ge, X., Deng, Y., Bible, P. W., & Wei, L. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.01.001 · Cited by 72
Elovanoids counteract oligomeric β-amyloid-induced gene expression and protect photoreceptors
Do, K. V., Kautzmann, M.-A. I., Jun, B., Gordon, W. C., Nshimiyimana, R., Yang, R., Petasis, N. A., & Bazan, N. G. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912959116 · Cited by 71
Fernandez-Godino, R., Bujakowska, K. M., & Pierce, E. A. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddx392 · Cited by 71
Sharafi, S. M., Sylvestre, J., Chevrefils, C., Soucy, J., Beaulieu, S., Pascoal, T. A., Arbour, J. D., Rhéaume, M., Robillard, A., Chayer, C., et al. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.09.006 · Cited by 70
MAPK, β-amyloid and synaptic dysfunction: the role of RAGE
Origlia, N., Arancio, O., Domenici, L., & Yan, S. S. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.107 · Cited by 70
Cao, L., Wang, H., Wang, F., Xu, D., Liu, F., & Liu, C. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-11612 · Cited by 68
Iannaccone, A., Giorgianni, F., New, D. D., Hollingsworth, T., Umfress, A. C., Alhatem, A., Neeli, I., Lenchik, N. I., Jennings, B., Calzada, J. I., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145323 · Cited by 68
Recent developments in the management of dry age-related macular degeneration
Buschini, E., Zola, M., FEA, A. M., Lavia, C. A., Nassisi, M., Pignata, G., & Grignolo, F. M. (2015) · Clinical Ophthalmology · doi:10.2147/opth.s59724 · Cited by 67
Complement-Associated Deposits in the Human Retina
Seth, A., Cui, J., To, E., Kwee, M., & Matsubara, J. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1072 · Cited by 67
Renzi, L. M., Hammond, B. R., Dengler, M., & Roberts, R. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-33 · Cited by 67
Ablonczy, Z., Prakasam, A., Fant, J., Fauq, A., Crosson, C., & Sambamurti, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032391 · Cited by 66
Simonelli, F. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.096487 · Cited by 66
Zhang, H., Jiang, W., Zhao, Y., Song, T., Xi, Y., Han, G., Jin, Y., Song, M., Bai, K., Zhou, J., et al. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c00191 · Cited by 65
Shimazawa, M., Inokuchi, Y., Okuno, T., Nakajima, Y., Sakaguchi, G., Kato, A., Oku, H., Sugiyama, T., Kudo, T., Ikeda, T., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05606.x · Cited by 65
Radeke, M. J., Peterson, K. E., Johnson, L. V., & Anderson, D. H. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.05.006 · Cited by 64
Self-citationSIRT1 negatively regulates amyloid-beta-induced inflammation via the NF-κB pathway
Cao, L., Liu, C., Wang, F., & Wang, H. (2013) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20132903 · Cited by 62
Zhao, Y., Bhattacharjee, S., Jones, B. M., Hill, J. M., Clement, C., Sambamurti, K., Dua, P., & Lukiw, W. J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8886-3 · Cited by 62
The Emerging Role of Senescence in Ocular Disease
Sreekumar, P. G., Hinton, D. R., & Kannan, R. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2583601 · Cited by 61
Fujihara, M., Bartels, E., Nielsen, L. B., & Handa, J. T. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.01.017 · Cited by 60
Raoul, W., Feumi, C., Keller, N., Lavalette, S., Houssier, M., Behar-Cohen, F., Combadière, C., & Sennlaub, F. (2008) · Ophthalmic Research · doi:10.1159/000119860 · Cited by 60
Drugs in Phase II clinical trials for the treatment of age-related macular degeneration
Tolentino, M. J., Dennrick, A., John, E., & Tolentino, M. S. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.961601 · Cited by 58
Fernandez-Godino, R., & Pierce, E. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-28143-0 · Cited by 58
Complement dysregulation in AMD: RPE-Bruch’s membrane-choroid
Sparrow, J. R., Ueda, K., & Zhou, J. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.03.007 · Cited by 57
Michalska‐Małecka, K., Kabiesz, A. M., Nowak, M., & Śpiewak, D. (2014) · European Geriatric Medicine · doi:10.1016/j.eurger.2014.09.007 · Cited by 57
Hu, M. L., Quinn, J., & Xue, K. (2021) · Life · doi:10.3390/life11070635 · Cited by 56
Distribution and composition of esterified and unesterified cholesterol in extra-macular drusen
Li, C., Clark, M. E., Rudolf, M., & Curcio, C. A. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.04.002 · Cited by 56
Trebbastoni, A., Marcelli, M., Mallone, F., D’Antonio, F., Imbriano, L., Campanelli, A., de Lena, C., & Gharbiya, M. (2016) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000176 · Cited by 56
Cąkała, M., Malik, A. R., & Strosznajder, J. B. (2007) · PubMed · Cited by 56
New therapeutic targets in atrophic age-related macular degeneration
Petrukhin, K. E. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.5.625 · Cited by 55
Complement regulation in the eye: implications for age-related macular degeneration
Wilke, G. A., & Apte, R. S. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178296 · Cited by 55
Reflections on the Utility of the Retina as a Biomarker for Alzheimer’s Disease: A Literature Review
Ngolab, J., Honma, P. S., & Rissman, R. A. (2019) · Neurology and Therapy · doi:10.1007/s40120-019-00173-4 · Cited by 55
New approaches and potential treatments for dry age-related macular degeneration
Damico, F. M., Gasparin, F., Scolari, M. R., Pedral, L. S., & Takahashi, B. S. (2012) · Arquivos Brasileiros de Oftalmologia · doi:10.1590/s0004-27492012000100016 · Cited by 54
Immunological and Anti-Chaperone Therapeutic Approaches for Alzheimer Disease
Wisniewski, T., & Frangione, B. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00102.x · Cited by 54
Is the Eye an Extension of the Brain in Central Nervous System Disease?
Groef, L. D., & Cordeiro, M. F. (2017) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2016.0180 · Cited by 54
YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer’s Disease
Mavroudis, I. A., Chowdhury, R., Petridis, F., Karantali, E., Chatzikonstantinou, S., Balmuș, I.-M., Luca, I. S., Ciobica, A. S., & Kazis, D. A. (2021) · Medicina · doi:10.3390/medicina58010060 · Cited by 54
Subretinal injection of amyloid-β peptide accelerates RPE cell senescence and retinal degeneration
Liu, C., Cao, L., Yang, S., Xu, L., Liu, P., Wang, F., & Xu, D. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1993 · Cited by 53
Emerging ocular biomarkers of Alzheimer disease
van Wijngaarden, P., Hadoux, X., Alwan, M., Keel, S., & Dirani, M. (2017) · Clinical & Experimental Ophthalmology · doi:10.1111/ceo.12872 · Cited by 52
Dasch, B. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.11.1501 · Cited by 51
Amyloidosis in Retinal Neurodegenerative Diseases
Masuzzo, A., Dinet, V., Cavanagh, C., Mascarelli, F., & Krantic, S. M. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00127 · Cited by 51
Pan, Y., Fu, Y., Baird, P. N., Guymer, R. H., Das, T., & Iwata, T. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101159 · Cited by 50
Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures
Yehoshua, Z., Rosenfeld, P. J., & Albini, T. A. (2011) · Seminars in Ophthalmology · doi:10.3109/08820538.2011.577132 · Cited by 50
Haas, P., Schmid‐Kubista, K. E., Krugluger, W., Huber, J. C., & Binder, S. (2015) · Acta Ophthalmologica · doi:10.1111/aos.12670 · Cited by 49
Can the retina be used to diagnose and plot the progression of Alzheimer's disease?
Mahajan, D., & Votruba, M. (2017) · Acta Ophthalmologica · doi:10.1111/aos.13472 · Cited by 49
Wang, J., Ohno‐Matsui, K., & Morita, I. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.085 · Cited by 48
Nerve Growth Factor-Based Therapy in Alzheimer’s Disease and Age-Related Macular Degeneration
Amadoro, G., Latina, V., Balzamino, B. O., Squitti, R., Varano, M., Calissano, P., & Micera, A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.735928 · Cited by 47
Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin
Parthasarathy, R., Chow, K. M., Derafshi, Z., Fautsch, M. P., Hetling, J. R., Rodgers, D. W., Hersh, L. B., & Pepperberg, D. R. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.06.027 · Cited by 47
Flinn, J. M., Kakalec, P. A., Tappero, R. V., Jones, B. F., & Lengyel, I. (2014) · Metallomics · doi:10.1039/c4mt00058g · Cited by 46
Wısnıewskı, T., & Sadowski, M. J. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s2-s5 · Cited by 46
MicroRNA target prediction in glaucoma
Romano, G. L., Platania, C. B. M., Forte, S., Salomone, S., Drago, F., & Bucolo, C. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.04.013 · Cited by 46
Therapeutic approaches for prion and Alzheimer's diseases
Wısnıewskı, T., & Sigurdsson, E. M. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05919.x · Cited by 45
Hammadi, S., Tzoumas, N., Ferrara, M., Meschede, I. P., Lo, K., Harris, C., Lako, M., & Steel, D. H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082870 · Cited by 44
Retinal Dysfunction in Alzheimer’s Disease and Implications for Biomarkers
Liao, C., Xu, J., Chen, Y., & Ip, N. Y. (2021) · Biomolecules · doi:10.3390/biom11081215 · Cited by 44
Zhao, T., Gao, J., Van, J., To, E., Wang, A., Cao, S., Cui, J. Z., Guo, J.-P., Lee, M., McGeer, P. L., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0337-1 · Cited by 44
Zhao, L., Wang, C., Song, D., Li, Y., Song, Y., Su, G., & Dunaief, J. L. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15025 · Cited by 44
The effect of aged microglia on synaptic impairment and its relevance in neurodegenerative diseases
Triviño, J. J., & von Bernhardi, R. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104982 · Cited by 43
Metadata
- Authors
- Johnson, L. V., Leitner, W. P., Rivest, A. J., Staples, M. K., Radeke, M. J., & Anderson, D. H.
- Affiliations
- University of California, Santa Barbara (US)
- Johns Hopkins University (US)
- ORCID
- Radeke, Monte J.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-08-20
- Volume
- 99
- Issue
- 18
- Pages
- 11830-11835
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC129354
- OpenAlex
- W2003101845
- Cited by
- 447
- References
- 45
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 14 · 2023: 8 · 2022: 17 · 2021: 20 · 2020: 20 · 2019: 14 · 2018: 19 · 2017: 26 · 2016: 24 · 2015: 34 · 2014: 38 · 2013: 21 · 2012: 23
- FWCI
- 8.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (R01EY011521, EY 11-521, R01EY011527, EY11527)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Keywords
- amyloid-beta, complement activation, age-related macular degeneration, drusen, retinal pigment epithelium, neuroinflammation, retinal aging, neuritic plaques, complement proteins
- MeSH terms
- Aged, Aged, 80 and over, Aging, Base Sequence, Complement Activation, Humans, Immunohistochemistry, Macular Degeneration, Middle Aged, Polymerase Chain Reaction, Amyloid beta-Peptides, DNA Primers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.